Tolerance to ”self” is a fundamental property of the immune system; its breakdown can lead to autoimmune diseases such as multiple sclerosis and diabetes. Selection processes in the thymus are essential for the generation of a self-tolerant T cell repertoire, either through removal of potentially dangerous T cells or through the induction of regulatory T cells. Our aim is to understand how the thymic microenvironment orchestrates these cell fate decisions.
Negative selection versus induction of regulatory T cells
It is well established that encounter of self-antigen during intrathymic development can lead to the “suicide” of potentially dangerous, autoreactive T cells. However, some T cells with specificity for self-antigens are spared from deletion and instead differentiate into so-called regulatory T cells. The parameters that influence the choice between these mechanisms of tolerance are not understood. One of our goals is to elucidate the developmental cues (stromal interaction partner, signal strength, maturation state) that control this developmental decision.
“Promiscuous” expression of self-antigens in the thymus
Deletion or re-programming of T cells upon encounter of self-antigens during intrathymic development is a cornerstone of immunological self-tolerance. We found that the range of self-antigens expressed in the thymus is unexpectedly broad. This so called “promiscuous” intrathymic expression of otherwise strictly tissue-specific proteins is confined to a particular cell type, medullary epithelial cells. We aim to elucidate the mechanistic basis for this phenomenon (e.g. specific induction versus de-repression of particular genes) and the consequences for particular T cell specificities (deletion versus induction of anergy/regulatory function).
Positive selection and the generation of a ‘useful’ T cell repertoire
Positive selection requires permissive interactions with a single antigen presenting cell (APC) type, namely cortical thymic epithelial cells (cTECs). Why positive selection depends on a single stromal cell type remains a conundrum, but it is becoming increasingly clear that the crucial role of cTECs is, at least in part, specified by unique machineries that these cells use to generate pMHC ligands. These proteolytic pathways are likely to endow cTECs with an at least in part ‘private’ self-peptide/major histocompatibility complex (pMHC) ligandome different from that on other APCs. In this context, we are addressing how the cTEC specific protease Cathepsin L shapes the CD4 T cell repertoire and imprints the functional competence of mature T cells.
ERC AdG742290: ERC-Advanced Grant "TOLERANCE FOOTPRINT"
DFG: LK1228/8-1 The role of cathepsin L in shaping a functional CD4 T cell repertoire
European Union H2020 Integrated Training Network (ITN) ENLIGHT-TEN+, ESR 3: Understanding determinants of T cell fate decisions through repertoire analyses Web-link: http://www.enlight-ten.eu/
Hassler, T., Urmann, E., Teschner, S., Federle, C., Dileepan, T., Schober, K., Jenkins, M.K., Busch, D.H., Hinterberger, M., and Klein, L. (2019). Inventories of naive and tolerant mouse CD4 T cell repertoires reveal a hierarchy of deleted and diverted T cell receptors. Proc Natl Acad Sci U S A 116:18537-18543. PMID: 31451631, https://www.ncbi.nlm.nih.gov/pubmed/31451631
Klein, L., Robey, E.A., and Hsieh, C.S. (2019). Central CD4(+) T cell tolerance: deletion versus regulatory T cell differentiation. Nat Rev Immunol 19:7-18. PMID: 30420705, https://www.ncbi.nlm.nih.gov/pubmed/30420705
von Rohrscheidt, J., Petrozziello, E., Nedjic, J., Federle, C., Krzyzak, L., Ploegh, H.L., Ishido, S., Steinkasserer, A., and Klein, L. (2016). Thymic CD4 T cell selection requires attenuation of March8-mediated MHCII turnover in cortical epithelial cells through CD83. J Exp Med 213:1685-1694. PMID: 27503071, https://www.ncbi.nlm.nih.gov/pubmed/27503071
Yamano, T., Nedjic, J., Hinterberger, M., Steinert, M., Koser, S., Pinto, S., Gerdes, N., Lutgens, E., Ishimaru, N., Busslinger, M., Brors, B., Kyewski, B., and Klein, L. (2015). Thymic B Cells Are Licensed to Present Self Antigens for Central T Cell Tolerance Induction. Immunity 42:1048-1061. PMID: 26070482, https://www.ncbi.nlm.nih.gov/pubmed/26070482